Breaking Down Coats Group plc Financial Health: Key Insights for Investors

Dive into Coats Group plc's financial snapshot: the supply-chain stalwart posted revenue of $1,501 million in 2024 (+8% year-on-year; +9% on a CER basis) driven by Apparel (+13%) and Footwear (+10%), while Performance Materials lagged, and H1 2025 revenue rose 2% CER; profitability showed momentum with adjusted EBIT of $270 million (+16%) and an adjusted EBIT margin of 18.0% (19.8% in H1 2025), adjusted basic EPS up to 9.5 cents and free cash flow of $153 million with a 101% cash conversion rate; leverage sits at net debt $449 million (net debt/EBITDA 1.91 in 2024, improving to 1.4x in H1 2025) alongside a planned $770 million acquisition of OrthoLite funded by new debt and up to 19.99% equity placing, while liquidity measures (current ratio 1.54, quick ratio 1.10) and operating cash flow of $185 million support solvency; valuation metrics (EV/EBITDA 8.73, EV/FCF 35.65, EV/Sales 1.62) and a consensus "Strong Buy" with an average analyst target of £121.25 round out the picture-read on for a section-by-section breakdown of risks, opportunities and what the numbers mean for investors.

Coats Group plc (COA.L) - Revenue Analysis

• Reported revenue (2024): $1,501 million (+8% year-over-year)
• CER revenue growth (2024): +9%
• Apparel revenue growth (2024): +13%
• Footwear revenue growth (2024): +10%
• Performance Materials: revenue decline in 2024, impacted by North America
• H1 2025 CER revenue growth: +2% (Apparel & Footwear positive; Performance Materials -2%)
• Outlook: full-year guidance maintained, supported by market share gains and strong operating margins

• Drivers: market share gains in apparel/footwear, resilient pricing, and operational leverage supporting margins.
• Risks: continued North American weakness in Performance Materials and currency volatility affecting reported rates.

Coats Group plc (COA.L) - Profitability Metrics

• Adjusted EBIT (2024): $270.0m - up 16% versus 2023, reflecting improved operational efficiency and cost discipline.
• Adjusted EBIT margin (2024, CER): 18.0% - above the 17% target set for the year.
• H1 2025 adjusted EBIT: $140.0m - +7% on H1 2024, with an adjusted EBIT margin of 19.8%, inside the company medium-term target range of 19-21%.
• Adjusted basic EPS (2024): 9.5 cents - an 18% increase year-over-year.
• Free cash flow (2024): $153.0m with cash conversion of 101% - indicates strong conversion of profits into cash.
• Net profit margin (latest reported): 5.34% - highlights scope to improve non-operating items, tax or interest impact to better convert revenue into net income.

• Operational leverage is visible: margin expansion from 18.0% (2024) to 19.8% (H1 2025) even as EBIT grew, indicating improved mix and cost control.
• Strong cash conversion (101%) supports reinvestment and balance sheet flexibility despite a modest net profit margin.
• EPS growth (18%) outpaced EBIT growth rate, suggesting share count dynamics or favorable tax/finance items in 2024.

Coats Group plc (COA.L) - Debt vs. Equity Structure

Coats Group plc's capital structure through FY 2024 and into H1 2025 shows material reliance on debt while maintaining operational coverage metrics that support servicing obligations.

• Net debt (excluding lease liabilities): $449 million (Dec 31, 2024) vs $384 million (2023).
• Debt-to-equity ratio: 1.96 (2024).
• Net debt / EBITDA: 1.91x (2024); improved to 1.4x in H1 2025.
• Interest coverage ratio: 5.47x (2024).
• Planned acquisition: OrthoLite Holdings LLC for $770 million, to be funded via new debt facilities and an equity placing of up to 19.99% of issued share capital.

Key implications for investors:

• Leverage: The FY 2024 net debt and debt-to-equity ratio reflect a debt-heavy structure but a manageable net debt/EBITDA (sub-2x) and solid interest coverage (5.47x).
• Acquisition funding: The $770m OrthoLite acquisition will materially affect capital structure unless the equity placing is used to offset new debt.
• Post-transaction trajectory: Improvement to 1.4x net debt/EBITDA in H1 2025 indicates de-leveraging momentum, aligning with the 1-2x target range.

For additional corporate context and stated values, see: Mission Statement, Vision, & Core Values (2026) of Coats Group plc.

Coats Group plc (COA.L) - Liquidity and Solvency

• Current ratio: 1.54 - indicates the company can cover short-term liabilities with short-term assets.
• Quick ratio: 1.10 - suggests adequate near-term liquidity without depending on inventory liquidation.
• Operating cash flow to net income ratio: 1.20 - reflects operating cash generation exceeding reported profit.
• Net cash position: -£501.20 million - a net debt position that affects solvency and financing flexibility.
• Free cash flow change: -26.71% (2023 → 2024) - a significant year-over-year decline in cash available after capex.

• Implications for short-term stress: liquidity ratios above 1.0 reduce immediate insolvency risk, but a negative net cash position increases refinancing and interest-rate exposure.
• Cash flow dynamics: while operating cash flow rose to $185m (from $124m), the 26.71% fall in free cash flow signals higher capex, working capital absorption, or one-off outflows deserving scrutiny.
• Key risk areas for investors to monitor:
  • Debt maturities and covenant headroom given -£501.20m net cash.
  • Drivers of the free cash flow decline and whether operating cash conversion can be sustained.
  • Working capital trends that may be pressuring cash despite stronger operating cash receipts.

Coats Group plc (COA.L) - Valuation Analysis

Key valuation metrics for Coats Group plc (COA.L) provide a snapshot of how the market prices the business relative to its income generation, cash flow and sales. Below are the principal ratios and contextual details investors typically track:

• Enterprise Value / EBITDA (EV/EBITDA): 8.73 - indicates valuation relative to operating profitability before non-cash and financing items.
• Enterprise Value / Free Cash Flow (EV/FCF): 35.65 - shows how richly (or conservatively) the market values the company's free cash flow generation.
• Enterprise Value / Sales (EV/Sales): 1.62 - reflects valuation versus revenue, useful for comparing across peers with different margin profiles.
• Average analyst price target: £121.25 - represents the consensus forward-looking price expectation from covering analysts.
• Consensus rating: Strong Buy - denotes overall analyst sentiment toward the shares.
• Index memberships: FTSE 250 Index and FTSE4Good Index - signals mid-cap market presence and adherence to recognized sustainability standards.

For background on the group's origins, ownership and business model, see: Coats Group plc: History, Ownership, Mission, How It Works & Makes Money

Coats Group plc (COA.L) - Risk Factors

Coats Group plc operates in a capital-intensive, global manufacturing environment where several concentrated risk factors can materially affect cash flow, margins and shareholder returns. Below are the primary risks investors should consider, illustrated with recent company-relevant numbers and quantifiable sensitivities where available.

• Market and trade policy exposure - tariffs, demand shocks
• End-market weakness in Performance Materials (North America)
• Balance sheet leverage and interest burden
• Acquisition and integration risk (notably OrthoLite)
• Foreign exchange translation and transaction risk
• Competitive pressures in industrial thread and footwear components

Key metrics (latest reported fiscal year shown where possible):

1. Market uncertainties and US tariff risk

• Potential US tariffs (or supply-chain disruption) could reduce US demand for sewn components and industrial thread by an estimated 1-4% of consolidated revenue in stressed scenarios.
• Given ~30% of revenue from the Americas, a sustained tumble in US demand has an outsized effect on group sales and working capital needs.

2. Weakness in Performance Materials - North America

• Performance Materials reported sequential underperformance: North American end-market weakness has trimmed segment growth and pressured margins.
• Segment sensitivity: a 5% decline in North American demand can reduce group revenue by ~1.5-2% and compress underlying operating margin by several hundred basis points.

3. Leverage and interest obligations

• Net debt roughly £350m with net-debt/EBITDA near 2.3x implies material exposure to rising rates - every 100 bps rise in average borrowing cost increases annual interest expense by ~£3-4m on drawn balances.
• High fixed-cost base (plant, logistics, input materials) limits rapid margin recovery if top line weakens, increasing refinancing and covenant risks in adverse cycles.

4. OrthoLite acquisition and integration risk

• Acquisition price of approximately $114m brings expected synergies but also integration costs and execution risk.
• Potential issues: cultural integration, systems harmonisation, retention of key customers and slower-than-expected synergy capture could defer or dilute projected returns.

5. Currency exposure

• With an approximate regional split EMEA ~40%, APAC ~30%, Americas ~30%, translation swings are non-trivial; a 5% adverse move in major trading currencies can lower reported revenue by £15-25m and reduce adjusted EPS.
• Transactional FX affects cost of inputs and margins in the near term where hedging is limited or mismatched.

6. Competitive pressures

• Coats operates in industrial thread and footwear components markets featuring low-cost global competitors and customer consolidation; pricing pressure could erode high-margin specialised revenue.
• Market position (estimated ~20% share in some industrial-thread categories) helps but does not insulate against margin compression from raw material inflation or aggressive competitor pricing.

Quantifying downside scenarios (illustrative):

Investor considerations when assessing these risks include covenant headroom, liquidity (available committed facilities vs. debt maturities), pace of OrthoLite integration, hedge program disclosures, and the company's stated strategy for margin recovery and working capital management. For broader context on corporate aims and principles, see: Mission Statement, Vision, & Core Values (2026) of Coats Group plc.

Coats Group plc (COA.L) Growth Opportunities

• Acquisition: OrthoLite Holdings LLC for $770 million - elevates Coats to a 'super tier 2' supplier in the high-growth insole segment and materially expands the footwear components portfolio.
• Organic growth target: management aims for over 5% average annual organic revenue growth, prioritising share gains and deeper customer penetration.
• Cash generation: plan to generate over $750 million in adjusted free cash flow across the next five years to support reinvestment, M&A and shareholder returns.
• Sustainability-led revenue: 73% increase in revenue from 100% recycled thread products, signalling strong market traction for eco-friendly offerings.
• Adjacency expansion: sales in organic adjacencies have increased by 30%, contributing meaningfully to top-line diversification.
• Digital & e-commerce: focused investments in digital capabilities and e-commerce platforms to broaden reach, streamline order-to-delivery and improve margin capture.

• Capital allocation stance: with strong FCF guidance, Coats can fund integration of OrthoLite, scale recycled-product lines and pursue bolt-on adjacencies while maintaining balance sheet flexibility.
• Revenue mix shift: increasing share from recycled threads and adjacent product lines reduces reliance on legacy thread volumes and taps higher-growth segments.
• Operational leverage: digital platform enhancements aim to reduce order costs and improve fulfilment speed, supporting margins as volumes grow.